Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NOVO NORDISK INDIA PRIVATE LIMITED

Home Clinical Trial Sponsors and OrganizationsNOVO NORDISK INDIA PRIVATE LIMITED

NOVO NORDISK INDIA PRIVATE LIMITED

New Jagruti Bldg227, Mumbai, Maharashtra, India

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

21

10 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

12

57.1%

Phase 2

4

19.1%

Phase 4

3

14.3%

Trial Status Distribution

Active, not recruiting

8

38.1%

Completed

8

38.1%

Not yet recruiting

2

9.5%

Recruiting

3

14.3%

Clinical Trials

Trials sponsored by this organization (21)

A research study looking at long-term treatment withMim8 in people with haemophilia A

Active, not recruiting

Mar 2024425 participants

A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes, compared to daily insulin glargine (COMBINE 4)

Feb 2024474 participants

A research study to see the effects of CagriSema on heart disease in people living with diseases in the heart and blood vessels

Sep 20234,000 participants

A research study looking at Mim8 in childrenwith haemophilia A with or without inhibitors

Sep 202370 participants

Study to know the safety and efficacy of once once weekly dosing of somapacitan with daily Norditropin in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature

Active, not recruiting

Apr 2023412 participants

Research study investigating how well NDec works in people with sickle cell disease

Active, not recruiting

Mar 202384 participants

A research study to understand how oral semaglutide works in people with type 2 diabetes in India

Feb 2023388 participants

A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly insulin icodec

Active, not recruiting

Jul 20221,290 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials21
Approvals
News

Back to Organizations